M&A / Deals Roche buys AI-powered diagnostics player PathAI PharmaphorumRoche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn.Read full story pharminent May 7, 2026 (Last updated: May 7, 2026) Pharmaphorum Roche has been working with US AI specialist PathAI for around five years, and has now upgraded that partnership with an offer to buy it for $1.05bn. Read full story Post navigation Previous: UCB and Cancer Research UK form expanded alliance to advance novel cancer therapiesNext: Bayer plans filings for cardiac amyloidosis imaging agent Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026